Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PML/RAR-ALPHA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 230 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rolston, RK; Kant, JA
      t(15;17) reverse transcription-polymerase chain reaction with alternative splicing

      JOURNAL OF MOLECULAR DIAGNOSTICS
    2. Grimwade, D
      The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    3. Dash, A; Gilliland, DG
      Molecular genetics of acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    4. Graessle, S; Loidl, P; Brosch, G
      Histone acetylation: plants and fungi as model systems for the investigation of histone deacetylases

      CELLULAR AND MOLECULAR LIFE SCIENCES
    5. Merghoub, T; Gurrieri, C; Piazza, F; Pandolfi, PP
      Modeling acute promyelocytic leukemia in the mouse: New insights in the pathogenesis of human leukemias

      BLOOD CELLS MOLECULES AND DISEASES
    6. Pollock, JL; Westervelt, P; Walter, MJ; Lane, AA; Ley, TJ
      Mouse models of acute promyelocytic leukemia

      CURRENT OPINION IN HEMATOLOGY
    7. Kohno, A; Tsuzuki, S; Kasai, M; Miyamura, K; Emi, N; Tanimoto, M; Saito, H
      Acute promyelocytic leukemia with apparently normal karyotype: Molecular findings and response to all-trans retinoic acid

      LEUKEMIA & LYMPHOMA
    8. Mathews, V; Chandy, M; Srivastava, A
      Arsenic trioxide in the management of acute promyelocytic leukaemia

      NATIONAL MEDICAL JOURNAL OF INDIA
    9. Pandolfi, PP
      Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia

      HUMAN MOLECULAR GENETICS
    10. Wu, XM; Pandolfi, PP
      Mouse models for multistep tumorigenesis

      TRENDS IN CELL BIOLOGY
    11. Hann, B; Balmain, A
      Building 'validated' mouse models of human cancer

      CURRENT OPINION IN CELL BIOLOGY
    12. de The, H; Chelbi-Alix, MK
      APL, a model disease for cancer therapies?

      ONCOGENE
    13. Zhang, TD; Chen, GQ; Wang, ZG; Wang, ZY; Chen, SJ; Chen, Z
      Arsenic trioxide, a therapeutic agent for APL

      ONCOGENE
    14. Cassinat, B; Chomienne, C
      Biological features of primary APL blasts: their relevance to the understanding of granulopoiesis, leukemogenesis and patient management

      ONCOGENE
    15. Benoit, G; Roussel, M; Pendino, F; Segal-Bendirdjian, E; Lanotte, M
      Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation

      ONCOGENE
    16. Lin, RJ; Sternsdorf, T; Tini, M; Evans, RM
      Transcriptional regulation in acute promyelocytic leukemia

      ONCOGENE
    17. Piazza, F; Gurrieri, C; Pandolfi, PP
      The theory of APL

      ONCOGENE
    18. Zhu, J; Lallemand-Breitenbach, V; de The, H
      Pathways of retinoic acid- or arsenic trioxide-induced PML/RAR alpha catabolism, role of oncogene degradation in disease remission

      ONCOGENE
    19. Roussel, MJS; Lanotte, M
      Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes

      ONCOGENE
    20. Pandolfi, PP
      In vivo analysis of the molecular genetics of acute promyelocytic leukemia

      ONCOGENE
    21. Kosugi, H; Ito, M; Yamamoto, Y; Towatari, M; Ito, M; Ueda, R; Saito, H; Naoe, T
      In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice

      JAPANESE JOURNAL OF CANCER RESEARCH
    22. Benoit, GR; Flexor, M; Besancon, F; Altucci, L; Rossin, A; Hillion, J; Balajthy, Z; Legres, L; Segal-Bendirdjian, E; Gronemeyer, H; Lanotte, M
      Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells

      MOLECULAR ENDOCRINOLOGY
    23. Muto, A; Kizaki, M; Kawamura, C; Matsushita, H; Fukuchi, Y; Umezawa, A; Yamada, T; Hata, J; Hozumi, N; Yamato, K; Ito, M; Ueyama, Y; Ikeda, Y
      A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF

      LEUKEMIA
    24. Tobal, K; Moore, H; Macheta, M; Yin, JAL
      Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RAR alpha transcripts with a sensitive competitive RT-PCR method

      LEUKEMIA
    25. Lallemand-Breitenbach, V; Zhu, J; de The, H
      Promyelocytic leukemia, a unique model to design treatments targeting oncogenes

      M S-MEDECINE SCIENCES
    26. Soignet, SL; Frankel, SR; Douer, D; Tallman, MS; Kantarjian, H; Calleja, E; Stone, RM; Kalaycio, M; Scheinberg, DA; Steinherz, P; Sievers, EL; Coutre, S; Dahlberg, S; Ellison, R; Warrell, RP
      United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    27. Ozpolat, B; Lopez-Berestein, G; Mehta, K
      ATRA(ouble) in the treatment of acute promyelocytic leukemia

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    28. Chillon, MC; Garcia-Sanz, R; Balanzategui, A; Ramos, F; Fernandez-Calvo, J; Rodriguez, MJ; Rodriguez-Salazar, MI; Corrales, A; Calmuntia, MJ; Orfao, A; Gonzalez, M; San Miguel, JF
      Molecular characterization of acute myeloblastic leukemia according to thenew WHO classification: a different distribution in Central-West Spain

      HAEMATOLOGICA
    29. Foley, R; Soamboonsrup, P; Carter, RF; Benger, A; Meyer, R; Walker, I; Wan, Y; Patterson, W; Orzel, A; Sunisloe, L; Leber, B; Neame, PB
      CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform

      AMERICAN JOURNAL OF HEMATOLOGY
    30. Asou, N; Adachi, K; Tamura, J; Kanamaru, A; Kageyama, S; Hiraoka, A; Omoto, E; Akiyama, H; Tsubaki, K; Saito, K; Kuriyama, K; Oh, H; Kitano, K; Miyawaki, S; Takeyama, K; Yamada, O; Nishikawa, K; Takahashi, M; Matsuda, S; Ohtake, S; Ohno, R
      Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group(JALSG)

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    31. Takayama, N; Kizaki, M; Hida, T; Kinjo, K; Ikeda, Y
      Novel mutation in the PML/RAR alpha chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoicacid in acute promyelocytic leukemia

      EXPERIMENTAL HEMATOLOGY
    32. Seeler, JS; Marchio, A; Losson, R; Desterro, JMP; Hay, RT; Chambon, P; Dejean, A
      Common properties of nuclear body protein SP100 and TIF1 alpha chromatin factor: Role of SUMO modification

      MOLECULAR AND CELLULAR BIOLOGY
    33. Tallman, MS
      Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies

      BLOOD REVIEWS
    34. Nabhan, C; Mehta, J; Tallman, MS
      The role of bone marrow transplantation in acute promyelocytic leukemia

      BONE MARROW TRANSPLANTATION
    35. Suzuki, H; Imaizumi, M; Sato, A; Yoshinari, M; Rikiishi, T; Endo, M; Takano, T; Shimizu, T; Hatae, Y; Fujimoto, T; Hayashi, Y; Iinuma, K
      Monitoring of minimal residual disease in children with acute promyelocytic leukemia by RT-PCR detecting PML/RAR alpha chimeric gene: A retrospectivestudy of clinical feasibility

      TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    36. Faretta, M; Di Croce, L; Pelicci, PG
      Effects of the acute myeloid leukemia-associated fusion proteins on nuclear architecture

      SEMINARS IN HEMATOLOGY
    37. Rego, EM; Pandolfi, PP
      Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models

      SEMINARS IN HEMATOLOGY
    38. Liao, C; Wang, XY; Wei, HQ; Li, SQ; Merghoub, T; Pandolfi, PP; Wolgemuth, DJ
      Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    39. Adamson, AL; Kenney, S
      Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies

      JOURNAL OF VIROLOGY
    40. Kogan, SC; Brown, DE; Shultz, DB; Truong, BTH; Lallemand-Breitenbach, V; Guillemin, MC; Lagasse, E; Weissman, IL; Bishop, JM
      BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRAR alpha) to block neutrophil differentiation and initiate acute leukemia

      JOURNAL OF EXPERIMENTAL MEDICINE
    41. Largaespada, DA
      Haploinsufficiency for tumor suppression: The hazards of being single and living a long time

      JOURNAL OF EXPERIMENTAL MEDICINE
    42. He, LZ; Tolentino, T; Grayson, P; Zhong, S; Warrell, RP; Rifkind, RA; Marks, PA; Richon, VM; Pandolfi, PP
      Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia

      JOURNAL OF CLINICAL INVESTIGATION
    43. Murges, D; Quadt, I; Schroer, J; Knebel-Morsdorf, D
      Dynamic nuclear localization of the baculovirus proteins IE2 and PE38 during the infection cycle: The promyelocytic leukemia protein colocalizes withIE2

      EXPERIMENTAL CELL RESEARCH
    44. Idres, N; Benoit, G; Flexor, MA; Lanotte, M; Chabot, GG
      Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites

      CANCER RESEARCH
    45. Mologni, L; Marchesi, E; Nielsen, PE; Gambacorti-Passerini, C
      Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid

      CANCER RESEARCH
    46. Ferrara, FF; Fazi, F; Bianchini, A; Padula, F; Gelmetti, V; Minucci, S; Mancini, M; Pelicci, PG; Lo Coco, F; Nervi, C
      Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia

      CANCER RESEARCH
    47. Petti, MC; Pinazzi, MB; Diverio, D; Romano, A; Petrucci, MT; De Santis, S; Meloni, G; Tafuri, A; Mandelli, F; Lo Coco, F
      Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg (TM) CMA-676)

      BRITISH JOURNAL OF HAEMATOLOGY
    48. Virchis, A; Massey, E; Butler, T; Devaraj, P; Wright, F; Secker-Walker, L; Prentice, HG; Mehta, A
      Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3

      BRITISH JOURNAL OF HAEMATOLOGY
    49. Gonzalez, M; Barragan, E; Bolufer, P; Chillon, C; Colomer, D; Borstein, R; Calasanz, MJ; Gomez-Casares, MT; Villegas, A; Marugan, I; Roman, J; Martin, G; Rayon, C; Deben, G; Tormo, M; Diaz-Mediavilla, J; Esteve, J; Gonzalez-San Miguel, J; Rivas, C; Perez-Equiza, K; Garcia-Sanz, R; Capote, FJ; Ribera, JM; Arias, J; Leon, A; Sanz, MA
      Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group

      BRITISH JOURNAL OF HAEMATOLOGY
    50. Jurcic, JG; Nimer, SD; Scheinberg, DA; DeBlasio, T; Warrell, RP; Miller, WH
      Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia

      BLOOD
    51. Kini, AR; Peterson, LC; Tallman, MS; Lingen, MW
      Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid

      BLOOD
    52. Gianni', M; Kalac, Y; Ponzanelli, I; Rambaldi, A; Terao, M; Garattini, E
      Tyrosine kinase inhibitor ST1571 potentiates the pharmacologic activity ofretinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RAR alpha and PML-RAR alpha

      BLOOD
    53. Douer, D
      Transcription therapy for acute promyelocytic leukaemia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    54. He, LZ; Bhaumik, M; Tribioli, C; Rego, EM; Ivins, S; Zelent, A; Pandolfi, PP
      Two critical hits for promyelocytic leukemia

      MOLECULAR CELL
    55. Parrado, A; Chomienne, C; Padua, RA
      Retinoic acid receptor alpha (RAR alpha) mutations in human leukemia

      LEUKEMIA & LYMPHOMA
    56. Sumimoto, Y; Maeda, Y; Naiki, Y; Sono, H; Miyatake, J; Sakaguchi, M; Matsuda, M; Kanamaru, A
      Establishment of a myeloid cell line, YM711, characterized by retinoid resistance

      LEUKEMIA & LYMPHOMA
    57. Huang, SY; Yang, CH; Chen, YC
      Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy

      LEUKEMIA & LYMPHOMA
    58. Laczika, K; Mitterbauer, G; Weltermann, A; Knobl, P; Thalhammer-Scherrer, R; Haas, OA; Lechner, K; Jaeger, U
      Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA)

      LEUKEMIA & LYMPHOMA
    59. Faderl, S; Kantarjian, HM; Talpaz, M; Estrov, Z
      Clinical significance of minimal residual disease in leukemia (Review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    60. Dhordain, P; Albagli, O; Honore, N; Guidez, F; Lantoine, D; Schmid, M; De The, H; Zelent, A; Koken, MHM
      Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF

      ONCOGENE
    61. Slack, JL; Rusiniak, ME
      Current issues in the management of acute promyelocytic leukemia

      ANNALS OF HEMATOLOGY
    62. Vickers, M; Jackson, G; Taylor, P
      The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation

      LEUKEMIA
    63. Kinjo, K; Kizaki, M; Muto, A; Fukuchi, Y; Umezawa, A; Yamato, K; Nishihara, T; Hata, J; Ito, M; Ueyama, Y; Ikeda, Y
      Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoicacid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice

      LEUKEMIA
    64. Waxman, S
      Differentiation therapy in acute myelogenous leukemia (non-APL)

      LEUKEMIA
    65. Cassinat, B; Zassadowski, F; Balitrand, N; Barbey, C; Rain, JD; Fenaux, P; Degos, L; Vidaud, M; Chomienne, C
      Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR

      LEUKEMIA
    66. Grolleau, A; Wietzerbin, J; Beretta, L
      Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NE4-R2

      LEUKEMIA
    67. Kitamura, K; Minami, Y; Yamamoto, K; Akao, Y; Kiyoi, H; Saito, H; Naoe, T
      Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis

      LEUKEMIA
    68. Gordon, JA; Pockwinse, SM; Stewart, FM; Quesenberry, PJ; Nakamura, T; Croce, CM; Lian, JB; Stein, JL; van Wijnen, AJ; Stein, GS
      Modified intranuclear organization of regulatory factors in human acute leukemias: Reversal after treatment

      JOURNAL OF CELLULAR BIOCHEMISTRY
    69. Meyers, S; Hiebert, SW
      Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia

      JOURNAL OF CELLULAR BIOCHEMISTRY
    70. Ma, ESK; Au, WY; Wan, TSK; Kwong, YL; Chan, LC
      Translocation (15;17)(q22;q21) not associated with acute promyelocytic leukemia and negative for PML/RAR alpha rearrangement

      HAEMATOLOGICA
    71. Breems-de Ridder, MC; Lowenberg, B; Jansen, JH
      Retinoic acid receptor fusion proteins: friend or foe

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    72. Mattson, JC
      Acute promyelocytic leukemia - From morphology to molecular lesions

      CLINICS IN LABORATORY MEDICINE
    73. Weil, SC
      Minimal residual disease in acute promyelocytic leukemia

      CLINICS IN LABORATORY MEDICINE
    74. Bartolo, C; Viswanatha, DS
      Molecular diagnosis in pediatric acute leukemias

      CLINICS IN LABORATORY MEDICINE
    75. Yamanaka, S; Zhang, XY; Maeda, M; Miura, K; Wang, S; Farese, RV; Iwao, H; Innerarity, TL
      Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway

      EMBO JOURNAL
    76. Zhang, JW; Gu, J; Wang, ZY; Chen, SJ; Chen, Z
      Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells

      JOURNAL OF BIOSCIENCES
    77. Hansen, LA; Sigman, CC; Andreola, F; Ross, SA; Kelloff, GJ; De Luca, LM
      Retinoids in chemoprevention and differentiation therapy

      CARCINOGENESIS
    78. Stewart, AK; Schuh, AC
      White cells 2: impact of understanding the molecular basis of haematological malignant disorders on clinical practice

      LANCET
    79. Zimonjic, DB; Pollock, JL; Westervelt, P; Popescu, NC; Ley, TJ
      Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    80. Rego, EM; He, LZ; Warrell, RP; Wang, ZG; Pandolfi, PP
      Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RAR alpha and PLZF-RAR alpha oncoproteins

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    81. Bolufer, P; Barragan, E; Sanz, MA; Martin, G; Lerma, E; de Ribera, EA
      Monitoring of minimal residual disease by combined detection of PML/RAR alpha and RAR alpha/PML rearrangements in acute promyelocytic leukemia

      MEDICINA CLINICA
    82. Rusiniak, ME; Yu, M; Ross, DT; Tolhurst, EC; Slack, JL
      Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia

      CANCER RESEARCH
    83. Kitamura, K; Hoshi, S; Koike, M; Kiyoi, H; Saito, H; Naoe, T
      Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid

      BRITISH JOURNAL OF HAEMATOLOGY
    84. Cote, S; Zhou, DC; Bianchini, A; Nervi, C; Gallagher, RE; Miller, WH
      Altered ligand binding and transcriptional regulation by mutations in the PML/RAR alpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia

      BLOOD
    85. Shao, WL; Rosenauer, A; Mann, K; Chang, CPB; Rachez, C; Freedman, LP; Miller, WH
      Ligand-inducible interaction of the DRTP/TRAP coactivator complex with retinoid receptors in retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells

      BLOOD
    86. Grimwade, D; Biondi, A; Mozziconacci, MJ; Hagemeijer, A; Berger, R; Neat, M; Howe, K; Dastugue, N; Jansen, J; Radford-Weiss, I; Lo Coco, F; Lessard, M; Hernandez, JM; Delabesse, E; Head, D; Liso, V; Sainty, D; Flandrin, G; Solomon, E; Birg, F; Lafage-Pochitaloff, M
      Characterization of acute promyelocytic leukemia cases lacking the classict(15;17): results of the European Working Party

      BLOOD
    87. Grignani, F; Valtieri, M; Gabbianelli, M; Gelmetti, V; Botta, R; Luchetti, L; Masella, B; Morsilli, O; Pelosi, E; Samoggia, P; Pelicci, PG; Peschle, C
      PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype

      BLOOD
    88. Wang, H; Zheng, X; Behm, FG; Ratnam, M
      Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia

      BLOOD
    89. Ponzanelli, I; Gianni, M; Giavazzi, R; Garofalo, A; Nicoletti, I; Reichert, U; Erba, E; Rambaldi, A; Terao, M; Garattini, E
      Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid

      BLOOD
    90. Ruiz-Arguelles, GJ; Ruiz-Delgado, GJ; Reyes-Nunez, V
      PML/RAR alpha(+) hypergranular acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/RAR alpha

      ACTA HAEMATOLOGICA
    91. Kizaki, M; Fukuchi, Y; Ikeda, Y
      A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    92. Rennert, H; Golde, T; Wilson, RB; Spitalnik, SL; Van Deerlin, VMD; Leonard, DGB
      A novel, non-nested reverse-transcriptase polymerase chain reaction (RT-PCR) test for the detection of the t(15;17) translocation: A comparative study of RT-PCR cytogenetics, and fluorescence in situ hybridization

      MOLECULAR DIAGNOSIS
    93. Evans, GD; Grimwade, DJ
      Extramedullary disease in acute promyelocytic leukemia

      LEUKEMIA & LYMPHOMA
    94. Varella-Garcia, M; Brizard, F; Roche, J; Flandrin, G; Drabkin, H; Brizard, A
      Aml1/ETO and Pml/RARA rearrangements in a case of AML-M2 acute myeloblastic leukemia with t(15;17)

      LEUKEMIA & LYMPHOMA
    95. O'Connor, SJM; Evans, PAS; Morgan, GJ
      Diagnostic approaches to acute promyelocytic leukaemia

      LEUKEMIA & LYMPHOMA
    96. Tamura, S; Takemoto, Y; Takami, S; Kinoshita, M; Kumano, Y; Aono, H; Mori, M; Kakishita, E
      Efficacy of all-trans retinoic acid for molecular relapse of acute promyelocytic leukemia during remission

      ONCOLOGY REPORTS
    97. Buchner, G; Montini, E; Andolfi, G; Quaderi, N; Cainarca, S; Messali, S; Bassi, MT; Ballabio, A; Meroni, G; Franco, B
      MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development

      HUMAN MOLECULAR GENETICS
    98. Grignani, F; Gelmetti, V; Fanelli, M; Rogaia, D; De Matteis, S; Ferrara, FF; Bonci, D; Grignani, F; Nervi, C; Pelicci, PG
      Formation of PML/RAR alpha high molecular weight nuclear complexes throughthe PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response

      ONCOGENE
    99. Kogan, SC; Bishop, JM
      Acute promyelocytic leukemia: from treatment to genetics and back

      ONCOGENE
    100. He, LZ; Merghoub, T; Pandolfi, PP
      In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications

      ONCOGENE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/21 alle ore 08:35:06